Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Week in Review

Summaries of each week's events in China biotech are provided free to all readers.  A weekly email newsletter providing direct links to these articles is also available - click here for free email newsletter...

Week in Review: Osaka Enters $445 Million Deal for Two Hearing Loss Candidates from France's Cilcare

Week in Review: Structure Reports Efficacy of Obesity Drug; Raises $476 Million

Week in Review: Week in Review: MediLink and BioNTech Form $1.8 Billion ADC Partnership

Week in Review: Hengrui and Dearon Announce $7.2 Billion in Drug Licensings

Week in Review: Takeda Options Alzheimer's Therapy from AC Immune in $2.2 Billion Deal

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital